SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Webinar date: August 20, 2020, at 1:30 PM EDT
This webinar was sponsored by the Assembly on Allergy, Immunology & Inflammation (AII), and featured the article: "SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness".
Presenter:
Kizzmekia Corbett, PhD, Scientific Lead of the Vaccine Research Center Coronavirus Team, National Institute of Allergy and Infectious Diseases, NIH
Moderator:
Catherine Bonham, MD, Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Virginia
